To model human stromal cells with a heterozygous BRCA1 mutation, we used BRCA1-mutant human induced pluripotent stem cells (iPSCs) derived from the blood cells of patients with an inherited form of breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.